Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2006 4
2007 5
2008 1
2009 1
2010 2
2011 3
2012 1
2013 4
2014 1
2015 2
2019 1
2020 3
2021 3
2022 10
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Adherent-invasive E. coli - induced specific IgA limits pathobiont localization to the epithelial niche in the gut.
Tanaka R, Imai J, Tsugawa H, Eap KB, Yazawa M, Kaneko M, Ohno M, Sugihara K, Kitamoto S, Nagao-Kitamoto H, Barnich N, Matsushima M, Suzuki T, Kagawa T, Nishizaki Y, Suzuki H, Kamada N, Hozumi K. Tanaka R, et al. Among authors: nishizaki y. Front Microbiol. 2023 Feb 23;14:1031997. doi: 10.3389/fmicb.2023.1031997. eCollection 2023. Front Microbiol. 2023. PMID: 36910191 Free PMC article.
A case of breast cancer with extensive colon metastasis.
Imai J, Hanamura T, Kawanishi A, Ueda T, Mishima Y, Ito A, Shirataki Y, Morimachi M, Kodama T, Sato H, Kaneko M, Sano M, Teramura E, Monma M, Tsuda S, Tsuruya K, Mizukami H, Arase Y, Fujisawa M, Miyahara S, Nakamura N, Suzuki T, Matsushima M, Suzuki H, Takashimizu S, Kagawa T, Nishizaki Y. Imai J, et al. Among authors: nishizaki y. DEN Open. 2022 Nov 27;3(1):e189. doi: 10.1002/deo2.189. eCollection 2023 Apr. DEN Open. 2022. PMID: 36447634 Free PMC article.
Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study).
Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Shinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. Kinoshita T, et al. Among authors: nishizaki y. BMC Med. 2022 Dec 8;20(1):478. doi: 10.1186/s12916-022-02695-5. BMC Med. 2022. PMID: 36482439 Free PMC article. No abstract available.
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study).
Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Shinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. Kinoshita T, et al. Among authors: nishizaki y. BMC Med. 2022 Sep 27;20(1):342. doi: 10.1186/s12916-022-02518-7. BMC Med. 2022. PMID: 36163020 Free PMC article. Clinical Trial.
46 results